142631-00-3

Basic information

• Product Name: 1D-2,3,4,5-O-tetrabenzoyl-myo-inositol
• Synonyms: 1D-2,3,4,5-O-tetrabenzoyl-myo-inositol
• CAS NO: 142631-00-3
• Molecular Weight: 596.59
• Mol File: 142631-00-3.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 1D-2,3,4,5-O-tetrabenzoyl-myo-inositol(CAS DataBase Reference)
• NIST Chemistry Reference: 1D-2,3,4,5-O-tetrabenzoyl-myo-inositol(142631-00-3)
• EPA Substance Registry System: 1D-2,3,4,5-O-tetrabenzoyl-myo-inositol(142631-00-3)

Safety Data

• Hazardous Substances Data: 142631-00-3(Hazardous Substances Data)

Upstream product

• 142630-96-4 1D-1,6-O-(1,1,3,3-tetraisopropyldisiloxanedi-1,3-yl)-2,3-O-(D-1',7',7'-trimethyl<2.2.1>bicyclohept-2'-ylidene)-myo-inositol 
• 142534-51-8 C₄₂H₆₀O₉Si₂ 
• 142534-59-6 1D-<1,6-(1,1,3,3-tetraisopropyldisiloxanedi-1,3-yl)>-myo-inositol 
• 98-88-4 benzoyl chloride 
• 128459-27-8 1D-2,3-O-(D-1',7',7'-trimethyl<2.2.1>bicyclohept-2'-ylidene)-myo-inositol 
• 87-89-8 D-myo-inositol 
• 33800-47-4 (+/-)-3,4,5,6-tetra-O-benzoyl-1,2-O-isopropylidene-myo-inositol 
• 39681-62-4 1,4,5,6-tetra-O-benzoyl-2,3-O-cyclohexylidene-myo-inositol 

Downstream Products

• 132760-98-6 2,4,5,6-tetra-O-benzoyl-1-O-benzyl-myo-inositol 
• 117655-16-0 1,4,5,6-tetra-O-benzoyl-3-O-benzyl-myo-inositol 
• 117655-16-0 1,4,5,6-tetra-O-benzoyl-2-O-benzyl-myo-inositol 

Relevant articles and documents

Practical synthesis of all inositol stereoisomers from myo-inositol

Synthesis of six inositol stereoisomers was successfully carried out via conduritol intermediates prepared from myo-inositol. Dihydroxylation and epoxidation followed by ring opening of the conduritol B, C and F derivatives gave epi-, allo-, muco-, neo-, DL-chiro- and scyllo-inositol. The cis- inositol derivative, which may not be prepared by this approach, was synthesized in 5 steps via 2-O-benzoyl-myo-inositol orthoformate as the key intermediate.

Efficient and systematic syntheses of enantiomerically pure and regiospecifically protected myo-inositols

Efficient and systematic syntheses of a variety of enantiomerically pure and regiospecifically protected myo-inositols, which can be readily used as precursors for most natural and unnatural derivatives of myo-inositol, have been developed. The key strate